Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription

Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription

Iodine-131 (I-131) therapy is one of the conventional approaches in the treatment of patients with differentiated thyroid carcinoma (DTC). The radioiodine agents also accumulate in the other organs that cause pain and damage to the patients. Radioiodine therapy is associated with various gastrointes...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehran Pashnehsaz, Abbas Takavar, Sina Izadyar, Seyed Zakariaee, Mahmoud Mahmoudi, Reza Paydar, Parham Geramifar
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2016-07-01
Series:World Journal of Nuclear Medicine
Subjects:
gastrointestinal (gi) side effects
radioiodine therapy
short-term side effects
thyroid cancer
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.174703
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items